Sign in Pull a receipt

FTH

Faeth Therapeutics, Inc.

Healthcare · Biotechnology

$84.19 sample

-0.79 (-0.93%) 1D

Market cap

$109.7B

Price as of

2026-10-29

Latest filing

8-K · 2026-10-13

Alerts

8

Price$84.19 +0.98% 3M daily closessample

86.5079.83

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 21INSInsider sell: General Counsel
Oct 13SEC8-K filed: material event
Oct 02INSInsider sell: Chief Executive Officer
Sep 24INSInsider sell: 10% owner
Sep 18INSInsider buy: Chief Financial Officer
Sep 15SEC8-K filed: material event
Sep 07INSInsider sell: Director
Sep 02SEC8-K filed: material event

Sign up to see the real FTH record →

Company facts

SEC EDGAR registration

Name: Faeth Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -3sample, -100 to +100
Reporting currency: USD

Who is positioning in FTH

sample

Insiders: 28 insider transactions over 90 days, net selling, $60.4M
Congress: 4 members traded over 90 days
Institutions · 13F: 12 funds hold $762.4M
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$6.1B +17.1% y/y

Q4 2024Q3 2026

Inventory$3.7B +20.5% y/y

Q4 2024Q3 2026

Accounts receivable$2.6B +9.1% y/y

Q4 2024Q3 2026

Total debt$7.2B +11.9% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $81.3B -9.3% 3M
Sample peer B: $48.9B -11.9% 3M
Sample peer C: $63.3B +1.1% 3M
Sample peer D: $45.2B -6.4% 3M
Sample peer E: $48.4B +11.3% 3M